Galux
AI for Protein Design
Seoul, South Korea · Founded 2020 · $29.0M raised
- Headquarters
- Seoul
- Founded
- 2020
- Website
- galux.co.kr
- Total Funding
- $29.0M
- Last Round
- $29.0M Series BFeb 2026
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Galux is an AI-driven protein therapeutics design platform that develops a pioneering de novo protein design platform for drug discovery. Founded in 2020 by Seoul National University chemistry professor Seok, the company revolutionizes protein therapeutic development through artificial intelligence.
Summary
Galux is an Artificial Intelligence company based in Seoul, South Korea, founded in 2020. It has raised $29.0M in total across 1 round, most recently a $29.0M Series B round in Feb 2026.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Feb 2026
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Lila Sciences combines artificial intelligence with autonomous laboratories to accelerate scienti...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/galux"><img src="https://indexed.vc/api/badge/company/galux" alt="Galux on Indexed.vc" width="260" height="76" /></a>